Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation
British Journal of Anaesthesia · 2025
DOI: 10.1016/j.bja.2025.02.038 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Anaesthesia, 2025. Verfasst von Douglas J Eleveld und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: d.j.eleve…. Hauptthemen laut MEDLINE: Hypnotics and Sedatives, Models, Biological, Benzodiazepines. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Pharmacokinetic-pharmacodynamic (PK-PD) models of remimazolam and their covariate relationships are useful for understanding drug disposition and predicting drug effects. Although clinical studies have shown that remimazolam induction doses decline with advancing age, this property is not reflected in existing models. The purpose of this investigation was to develop a PK-PD model for remimazolam and perform covariate analysis to maximise its utility across broad, diverse populations and to evaluate its consistency with clinical observations of drug dosing. METHODS: Arterial and venous concentrations of remimazolam and its metabolite, Modified Observer's Assessment of Alertness and Sedation score and bispectral index were determined in 20 studies. Final population models were developed with covariate analysis. Simulations of drug administration for sedation and anaesthesia for this and previously published models were compared with the results of clinical studies. RESULTS: Model development proceeded from 933 individuals aged 6-93 yr and weight 21-171 kg. PK data from studies with extracorporeal membrane oxygenation and treatment in ICU were considered in a post hoc analysis. Simulations of target-controlled infusion with the final model targeting sedation (Modified Observer's Assessment of Alertness and Sedation score 2 or 3) or anaesthesia (bispectral index 50) showed drug administration declining with age consistent with clinical observations. CONCLUSIONS: A PK-PD model for remimazolam was developed for a broad, diverse population. Dosing and target concentrations are proposed that are clinically useful for anaesthesia and sedation, especially for target-controlled infusion administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: d.j.eleveld@umcg.nl.
- Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Paion Pharma GmbH, Aachen, Germany.
- Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Basic and Applied Medical Sciences, Ghent University, Ghent, Belgium.
Zitieren
APA
Eleveld, D. J., Colin, P. J., Van den Berg, J. P., Koomen, J. V., Stoehr, T., & Struys, M. M. R. F. (2025). Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2025.02.038
Vancouver
Eleveld DJ, Colin PJ, Van den Berg JP, Koomen JV, Stoehr T, Struys MMRF. Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation. British Journal of Anaesthesia. 2025. doi:10.1016/j.bja.2025.02.038
BibTeX
@article{Eleveld2025,
author = {Eleveld, Douglas J and Colin, Pieter J and Van den Berg, Johannes P and Koomen, Jeroen V and Stoehr, Thomas and Struys, Michel M R F},
title = {Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation},
journal = {British Journal of Anaesthesia},
year = {2025},
doi = {10.1016/j.bja.2025.02.038}
}
EUVIMED